WHAT’S NEW?

The Neuro-CERVO Alliance Partners with Montreal-based AI Company Simmunome to Understand Neurological Disease Mechanisms and Accelerate Drug Development

MONTREAL, Canada, July 18, 2023 In the newly established initiative, the Neuro-CERVO Alliance for Drug Discovery (NCADD) is welcoming a new Montreal-based private partner, Simmunome, to untangle biological pathways and…

Read the article

The Neuro-CERVO Alliance Partners with Montreal-based AI Company Simmunome to Understand Neurological Disease Mechanisms and Accelerate Drug Development

MONTREAL, Canada, July 18, 2023 In the newly established initiative, the Neuro-CERVO Alliance for Drug…

Read the article

Neuro Genomics Partnership (NGP)

A New Consortium Dedicated to a Fully Open Patient to Patient (P2P) Integrative R&D Approach.…

Read the article

New Quebec neuroscience partnership awarded $7M

The Neuro and the CERVO Brain Research Centre join forces to pave the way for…

Read the article

Open Science to speed up the drug discovery process

How can sharing data openly accelerate PD research? https://www.mcgill.ca/neuro/article/open-science-stories-research-stories/accelerating-drug-discovery-open-science

Read the article